Skip to main content
Have a personal or library account? Click to login
Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties Cover

Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties

Open Access
|Feb 2007

References

  1. S. G. Kapsi and J. W. Ayres, Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability,229 (2001) 193-203.
  2. A. J. Aguiar, A. J. Zelmer and A. W. Kinkel, Deagglomeration behavior of relatively insoluble benzoic acid and its sodium salt,56 (1967) 1243-1252.
  3. P. Finholt and S. Solvang, Dissolution kinetics of drugs in human gastric juice; the role of surface tension,57 (1968) 1322-1326.
  4. S. L. Lin, J. Menig and L. Lachman, Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs,57 (1968) 2143-2146.
  5. S. Spireas and S. Sadu, Enhancement of prednisolone dissolution properties using liquisolid compacts,166 (1998) 177-188.
  6. S. Spireas, S. Sadu and R. Grover, In vitro release evaluation of hydrocortisone liquisolid tablets,87 (1998) 867-872.
  7. S. Spireas, T. Wang and R. Grover, Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts,25 (1999) 163-168.
  8. K. Y. Yang, R. Glemza and C. I. Jarowski, Effect of amorphous silicon dioxide on drug dissolution,68 (1979) 560-565.
  9. C. Liao and C. I. Jarowski, Dissolution rates of corticoid solutions dispersed on silicas,73 (1984) 401-403.
  10. A. Nokhodchi, Y. Javadzadeh, M. R. Siahi and M. Barzegar-Jalali, The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts,8 (2005) 18-25.
  11. , USP Convention, Rockville 2003.
  12. P. Costa, An alternative method to the evaluation of similarity factor in dissolution testing,220 (2001) 77-83.
  13. P. Costa and J. M. S. Lobo, Modelling and comparison of dissolution profiles,13 (2001) 123-133.
  14. K. A. Khan, Concept of dissolution efficiency,27 (1975) 48-49.
  15. H. Abdou, Effect of the physicochemical properties of the drug on dissolution in Dissolution, Bioavailability and Bioequivalence (Ed. H. Abdou), Edison Mack Publishing Co., Easton, PA 1989, pp. 53-72.
  16. N. Kaneniwa, M. Otsuka and T. Hayashi, Physicochemical characterization of indomethacin polymorphs and transformation kinetics in ethanol,33 (1985) 3447-3455.
  17. H. Imaizumi, N. Nambu and T. Nagai, Stability of several physical properties of amorphous and crystalline forms of indomethacin,28 (1980) 2565-2569.
  18. L. Borka, Polymorphism of indomethacin. New modifications, their melting behavior and solubility,11 (1974) 295-303.
  19. M. Otsuka, F. Kato and Y. Matsuda, Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry,126 (2001) 1578-1582.
  20. M. Yoshioka, B.C. Hancock and G. Zografi, Crystallization of indomethacin from the amorphous state below and above its glass transition temperature,83 (1994) 1700-1705.
  21. H. Imaizumi, N. Nambu and T. Nagai, Stabilization of amorphous state of indomethacin by solid dispersions in polyvinylpyrolidone,31 (1983) 2510-2512.
DOI: https://doi.org/10.2478/v10007-007-0008-6 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 99 - 109
Published on: Feb 28, 2007
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2007 Yousef Javadzadeh, Mohammad Siahi, Solmaz Asnaashari, Ali Nokhodchi, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.